1Fasano M, Sabatini MT, Wieczorek R, et al. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis? Cancer,1997,80: 34-41.
2Kondo K, Miyoshi T, Hino N, et al. High frequency expression of CIN4 standard and variant forms in non-small cell lung carcinomas,but not in small cell lung carcinomas. J Surg Oncol, 1998,69:128-136.
3Sell S,Pierce GIK Maturation arrest of stem cell differentiation is a common pathway for the origin of terate carcinomas and epithelial cancers. Lab Invest, 1994,70: 6-22.
4Tran TA, Kallakury BV, Carter J, et al. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Hum Pathol, 1997,28 : 809-814.
5Miyoshi T,Kondo K, H ino N, et al. The expresion of CD44 variant exon 6 is associated with lymph node metastatasis in nonsmall cell lung cancer. Clin Cancer Res. 1997.8:1289-1297.
6Noriharu S, Toshimitsu U,Shigeyuki K,et al. Vascular endothelial growth factor and osteopontin in stage 1 lung adenocarcinoma[J].Am J Respir Crit Care Med,1999,160:1269 -73.
8Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signallingregulators. Nature Rev Mol Cell Biol, 2003,4:33-45.
9Fujita N, Yaegashi N,Ide Y, et al. Expression of CD44 in normal human versustumorendometrial tissues: possible implication of reduced expression of CD44 in lymph vascularspace involvement of cancer cells [J]. Cancer res, 1994,54 (14) :3922 - 8.
10Mathew J, Hines JE, Obafunwa JO, et al. CD44 is expressed in hepatocellular carcinomasshowing vascular invasion [J]. J Pathol,1996,179:74 - 9.
